ID: ALA4464414

Max Phase: Preclinical

Molecular Formula: C33H40F3N7O10S

Molecular Weight: 669.76

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cc(OC)c(C(=O)Nc2c[nH]nc2C(=O)NC2CCN(S(=O)(=O)c3cccc(NC(=O)/C=C/CN(C)C)c3)CC2)c(OC)c1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C31H39N7O8S.C2HF3O2/c1-37(2)13-7-10-27(39)33-21-8-6-9-23(16-21)47(42,43)38-14-11-20(12-15-38)34-31(41)29-24(19-32-36-29)35-30(40)28-25(45-4)17-22(44-3)18-26(28)46-5;3-2(4,5)1(6)7/h6-10,16-20H,11-15H2,1-5H3,(H,32,36)(H,33,39)(H,34,41)(H,35,40);(H,6,7)/b10-7+;

Standard InChI Key:  BJPZBZHYCSNPHD-HCUGZAAXSA-N

Associated Targets(Human)

CDK14 Tchem Cyclin-dependent kinase 14/Cyclin-Y (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 669.76Molecular Weight (Monoisotopic): 669.2581AlogP: 2.33#Rotatable Bonds: 13
Polar Surface Area: 184.29Molecular Species: BASEHBA: 10HBD: 4
#RO5 Violations: 1HBA (Lipinski): 15HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.74CX Basic pKa: 8.80CX LogP: 1.58CX LogD: 0.26
Aromatic Rings: 3Heavy Atoms: 47QED Weighted: 0.20Np Likeness Score: -1.41

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source